Stocks To Watch On 20 April 2026: HDFC Bank, ICICI Bank, Jio Financial Services & More
- By Kotak News Desk
- 20 Apr 2026 at 9:02 AM IST
- Market News
- 4m

Markets set to open higher as global cues strengthen. HDFC Bank, ICICI Bank post strong earnings; Jio Financial sees sharp growth. Cipla, Lupin under FDA lens; Trent eyes bonus issue.
The Indian equity indices are expected to open in the green as the GIFT Nifty registered a surge of 1.15% to touch the mark of 24,700 as of 6:15 a.m. Moreover, the futures of global indices like the S&P 500 and the Euro Stoxx 50 reported a surge of 1.2% and 2.1%.
Stocks To Watch
Here are some of the stocks to watch:
HDFC Bank: In Q4FY26, the bank reported better than expected net profit of ₹19,221 crore and net interest income of ₹33,081.5 crore.
ICICI Bank: The company’s net profit grew to ₹13,701.7 crore in Q4FY26, registering a growth rate of 8.5% year-on-year.
Jio Financial Services: The company reported a growth of 29% in its net interest income, and its AUM rose by 156% year-on-year.
Yes Bank: In the March quarter of FY26, the company’s core income grew by 16% year-on-year to ₹2,637.7 crore with a net profit of ₹1,064.8 crore.
Mastek: In Q4FY26, the company’s net profit decreased from ₹108.4 crore to ₹106.2 crore on a sequential basis. However, the revenue grew by 3.6% quarter-on-quarter to ₹938 crore.
Trent: The company is considering issuing its first-ever bonus shares after its board meeting on 22 April.
Network18: In the recent quarterly report, the company registered a growth of 9.7% in its operating revenue.
Cipla: The US FDA carried out an inspection at Cipla’s Goa manufacturing facility from 6 April to 17 April, covering both a routine current Good Manufacturing Practices (cGMP) review and a Pre-Approval Inspection (PAI).
Lupin: The US FDA has completed its inspection of Lupin’s manufacturing facility in Somerset, New Jersey, and issued a Form 483 citing three observations.
Also Read - Pre-Market 20 April 2026
Sources
CNBC TV18
Moneycontrol
NDTV Profit
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit. The securities are quoted as an example and not as a recommendation. SEBI Registration No-INZ000200137 Member Id NSE-08081; BSE-673; MSE-1024, MCX-56285, NCDEX-1262.

Kotak News Desk brings you latest updates, expert insights, and market-ready ideas - helping you stay informed and invest smarter.
Connect on: Linkedin
0 people liked this article.




